US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

OKYO Pharma Limited

1.36

-0.2025-12.94%

Post-market: 1.450.0875+6.42%18:47 EDT

Volume:56.76K

Turnover:81.75K

Market Cap:46.24M

PE:-4.24

High:1.60

Open:1.60

Low:1.31

Close:1.57

Loading ...

Overview Company News Filings

Okyo Pharma announces FDA granted FTD to urcosimod

OKYO Pharma Ltd. Announces FDA Fast Track Designation for Urcosimod in Treating Neuropathic Corneal Pain

FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain

OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain

OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod

OKYO Pharma Seeks FDA Fast Track for Urcosimod in Treating Neuropathic Corneal Pain

OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain

OKYO Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

H.C. Wainwright Sticks to Its Buy Rating for OKYO Pharma Limited Sponsored ADR (OKYO)

OKYO Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Buy Recommendation for OKYO Pharma Driven by Promising Urcosimod Efficacy and Market Potential

OKYO Pharma’s Lead Asset OK-101 Receives USAN as Urcosimod

Okyo Pharma announces OK-101 officially assigned USAN, urcosimod

OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod

OKYO Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Yi Chen’s Buy Recommendation on OKYO Pharma: Promising Potential of OK-101 for Neuropathic Corneal Pain Amid Financial and Regulatory Challenges

Okyo Pharma CEO purchases 10,000 shares of company

OKYO Pharma Announces Chairman and CEO Acquire Shares

Goldman Small Cap Research Publishes New Research Report on OKYO Pharma Limited

ACCESS Newswire

OKYO Pharma Advances Clinical Trials with Encouraging Interim Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OKYO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OKYO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OKYO\",,,,,undefined,":{"symbol":"OKYO","market":"US","secType":"STK","nameCN":"OKYO Pharma Limited","latestPrice":1.3625,"timestamp":1746216000000,"preClose":1.565,"halted":0,"volume":56762,"hourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.3625,"latestTime":"18:47 EDT","volume":5803,"amount":8027,"timestamp":1746226023850},"delay":0,"floatShares":24001647,"shares":33936582,"eps":-0.321215,"marketStatus":"Market Closed","change":-0.2025,"latestTime":"05-02 16:00:00 EDT","open":1.6,"high":1.6,"low":1.3101,"amount":81751.5329382,"amplitude":0.18524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.321215,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":65,"listingDate":1652760000000,"exchange":"NASDAQ","adjPreClose":1.565,"preHourTrading":{"tag":"盘前","latestPrice":1.5,"preClose":1.57,"latestTime":"09:19 EDT","volume":140,"amount":211.68,"timestamp":1746191960628},"postHourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.3625,"latestTime":"18:47 EDT","volume":5803,"amount":8027,"timestamp":1746226023850},"volumeRatio":0.6875941842663676},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OKYO\",,,,,undefined,":{"symbol":"OKYO","floatShares":24001647,"roa":"-291.87%","roe":"-2968.51%","lyrEps":-0.573392,"volumeRatio":0.6875941842663676,"shares":33936582,"dividePrice":0,"high":1.6,"amplitude":0.18524,"preClose":1.565,"low":1.3101,"week52Low":0.8075,"pbRate":"-6.40","week52High":1.74,"institutionHeld":0,"latestPrice":1.3625,"eps":-0.321215,"divideRate":0,"volume":56762,"delay":0,"ttmEps":-0.321215,"open":1.6,"prevYearClose":1.1499,"prevWeekClose":1.51,"prevMonthClose":1.585,"prevQuarterClose":1.27,"fiveDayClose":1.51,"twentyDayClose":1.2263,"sixtyDayClose":1.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OKYO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532653075","title":"Okyo Pharma announces FDA granted FTD to urcosimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2532653075","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532653075?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:20","pubTimestamp":1746098459,"startTime":"0","endTime":"0","summary":"OKYO Pharma (OKYO) announces that the U.S. Food and Drug Administration, FDA, has granted Fast Track designation, FTD, to urcosimod for the treatme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/okyo-pharma-announces-fda-granted-ftd-to-urcosimod?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/okyo-pharma-announces-fda-granted-ftd-to-urcosimod?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BYQQ9H92.USD","BK4588","BK4567","BK4104","IE00BFXG0V08.USD","BK4139","OKYO","FAST","IE00B5TLWC47.USD","BK4585"],"gpt_icon":0},{"id":"2532075099","title":"OKYO Pharma Ltd. Announces FDA Fast Track Designation for Urcosimod in Treating Neuropathic Corneal Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2532075099","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532075099?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:01","pubTimestamp":1746097277,"startTime":"0","endTime":"0","summary":"OKYO Pharma Ltd. has announced that the U.S. Food and Drug Administration  has granted Fast Track designation to its innovative drug, urcosimod, for the treatment of neuropathic corneal pain . This designation is intended to expedite the development and review process for therapies addressing serious conditions with unmet medical needs. Neuropathic corneal pain is a debilitating condition characterized by severe eye pain due to nerve damage, affecting patients worldwide. OKYO Pharma is committed to advancing urcosimod through clinical development and regulatory review to provide an effective treatment option for this condition. The Fast Track designation allows for more frequent meetings with the FDA, eligibility for Accelerated Approval and Priority Review, and potential Rolling Review of the New Drug Application, which could significantly accelerate the availability of urcosimod to patients.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nNDL3rm8NB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OKYO"],"gpt_icon":0},{"id":"2532079428","title":"FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2532079428","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532079428?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:00","pubTimestamp":1746097200,"startTime":"0","endTime":"0","summary":"LONDON and NEW YORK, May 01, 2025  -- OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod  to treat NCP, an ocular condition associated with chronic and often severe pain but without an FDA-approved therapy, announces that the U.S. Food and Drug Administration  has granted Fast Track designation to urcosimod for the treatment of neuropathic corneal pain .Fast Track designation by the FDA is granted to facilitate the development and expedite the review of therapies that aim to treat serious conditions and fulfill unmet medical needs. This designation is intended to accelerate the availability of new treatments to patients, providing earlier access to potentially beneficial therapies. The Fast Track designation provides several key benefits, including more frequent meetings with the FDA to discuss the drug’s development plan, eligibility for Accelerated Approval and Priority Review if relevant criteria are met, and a potential Rolling R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-grants-okyo-pharma-fast-110000481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","SQQQ","USAW.SI","BK4139","TSYW.SI",".IXIC","QID","NQmain","NVIW.SI","FAST","OKYO","MNQmain","QQQ","PSQ","USJW.SI","TQQQ"],"gpt_icon":0},{"id":"2531880038","title":"OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2531880038","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531880038?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:00","pubTimestamp":1746010800,"startTime":"0","endTime":"0","summary":"Urcosimod phase 2 trial treating Neuropathic Corneal Pain  patients was initiated in October 2024 and designed as a double-masked, randomized, 12-week placebo-controlled trial.OKYO Pharma plans to analyze the efficacy data from the 17 patients who have now completed the Phase 2 trial.OKYO Pharma plans for a meeting with FDA following evaluation of clinical data.LONDON and NEW YORK, April 30, 2025  -- OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod  to treat NCP, an ocular condition associated with chronic and often severe pain but without an FDA-approved therapy, announces plans to accelerate the clinical development of urcosimod to treat NCP through the analysis of its data following the early closure of its Phase 2 trial.About NCPNeuropathic corneal painis a condition that causes severe pain and sensitivity of the eyes, face, or head. The exact cause of neuropathic corneal pain is unknown but is thought to result from nerve dama","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/okyo-pharma-announces-plans-accelerate-110000750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OKYO","BK4139","AAQC"],"gpt_icon":0},{"id":"2523259945","title":"OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2523259945","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523259945?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422400,"startTime":"0","endTime":"0","summary":"Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for more than 2 yearsFDA requires drug to show long-term shelf","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/31/3052220/0/en/OKYO-Pharma-Announces-Positive-Data-in-Long-Term-Stability-of-Urcosimod.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMC","LU1363072403.SGD","LU0882574139.USD","BK4006","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00BHPRN162.USD","LU0170899867.USD","LU0267386448.USD","LU0149725797.USD","IE00B1BXHZ80.USD","OKYO","LU0971096721.USD","BK4139"],"gpt_icon":0},{"id":"2518306229","title":"OKYO Pharma Seeks FDA Fast Track for Urcosimod in Treating Neuropathic Corneal Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2518306229","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518306229?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:57","pubTimestamp":1741611468,"startTime":"0","endTime":"0","summary":"An update from OKYO Pharma Limited Sponsored ADR ( ($OKYO) ) is now available. On March 10, 2025, OKYO Pharma Limited announced the filing of an ap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/okyo-pharma-seeks-fda-fast-track-for-urcosimod-in-treating-neuropathic-corneal-pain?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/okyo-pharma-seeks-fda-fast-track-for-urcosimod-in-treating-neuropathic-corneal-pain?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFXG0V08.USD","IE00BYQQ9H92.USD","IE00B5TLWC47.USD","BK4104","BK4585","OKYO","BK4139","FAST","BK4588","BK4567"],"gpt_icon":0},{"id":"2518225740","title":"OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2518225740","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518225740?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:30","pubTimestamp":1741609800,"startTime":"0","endTime":"0","summary":"LONDON and NEW YORK, March  10, 2025  (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039726/0/en/OKYO-Pharma-Files-for-Fast-Track-Designation-with-FDA-for-Urcosimod-to-Treat-Neuropathic-Corneal-Pain.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","NQmain","NVIW.SI","OKYO","SQQQ","USAW.SI","USJW.SI","TSYW.SI","BK4139",".IXIC","QID","QLD","MNQmain","FAST","TQQQ"],"gpt_icon":1},{"id":"2512159020","title":"OKYO Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2512159020","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512159020?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:18","pubTimestamp":1739881080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OKYO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 18, 2025 07:18 ET (12:18 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKYO"],"gpt_icon":0},{"id":"2512949159","title":"H.C. Wainwright Sticks to Its Buy Rating for OKYO Pharma Limited Sponsored ADR (OKYO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2512949159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512949159?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:08","pubTimestamp":1739880527,"startTime":"0","endTime":"0","summary":"In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on OKYO Pharma Limited Sponsored ADR (OKYO – Research Report), wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-okyo-pharma-limited-sponsored-adr-okyo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-okyo-pharma-limited-sponsored-adr-okyo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKYO"],"gpt_icon":0},{"id":"2511615867","title":"OKYO Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2511615867","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511615867?lang=en_us&edition=fundamental","pubTime":"2025-02-15 02:11","pubTimestamp":1739556660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OKYO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 14, 2025 13:11 ET (18:11 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKYO"],"gpt_icon":0},{"id":"2511613425","title":"Buy Recommendation for OKYO Pharma Driven by Promising Urcosimod Efficacy and Market Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2511613425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511613425?lang=en_us&edition=fundamental","pubTime":"2025-02-15 01:25","pubTimestamp":1739553914,"startTime":"0","endTime":"0","summary":"OKYO Pharma Limited Sponsored ADR (OKYO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-recommendation-for-okyo-pharma-driven-by-promising-urcosimod-efficacy-and-market-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-recommendation-for-okyo-pharma-driven-by-promising-urcosimod-efficacy-and-market-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKYO","BK4139"],"gpt_icon":0},{"id":"2510375510","title":"OKYO Pharma’s Lead Asset OK-101 Receives USAN as Urcosimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2510375510","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510375510?lang=en_us&edition=fundamental","pubTime":"2025-02-12 20:28","pubTimestamp":1739363294,"startTime":"0","endTime":"0","summary":"The latest update is out from OKYO Pharma Limited Sponsored ADR ( ($OKYO) ). On February 12, 2025, OKYO Pharma announced that its lead asset, OK-10...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/okyo-pharmas-lead-asset-ok-101-receives-usan-as-urcosimod?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/okyo-pharmas-lead-asset-ok-101-receives-usan-as-urcosimod?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKYO","BK4139"],"gpt_icon":0},{"id":"2510837580","title":"Okyo Pharma announces OK-101 officially assigned USAN, urcosimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2510837580","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510837580?lang=en_us&edition=fundamental","pubTime":"2025-02-12 20:27","pubTimestamp":1739363277,"startTime":"0","endTime":"0","summary":"OKYO Pharma (OKYO) announces that its lead asset, OK-101, has been officially assigned the United States Adopted Name, USAN, “urcosimod”. Gary Jaco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/okyo-pharma-announces-ok-101-officially-assigned-usan-urcosimod?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/okyo-pharma-announces-ok-101-officially-assigned-usan-urcosimod?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKYO","BK4139"],"gpt_icon":0},{"id":"2510378223","title":"OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2510378223","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510378223?lang=en_us&edition=fundamental","pubTime":"2025-02-12 20:00","pubTimestamp":1739361600,"startTime":"0","endTime":"0","summary":"LONDON and NEW YORK, Feb. 12, 2025  -- OKYO Pharma Limited , a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain , a severe ocular condition without an FDA approved therapy, and for inflammatory dry eye disease , a multi-billion-dollar market, is pleased to announce that its lead asset, OK-101, has been officially assigned the United States Adopted Name  \"urcosimod\".The USAN designation reflects Okyo Pharma’s commitment to developing new therapies for unmet medical needs in ophthalmology. The suffix “-mod” in urcosimod denotes its classification as a modulator of key inflammatory and neuropathic pathways, critical to addressing ocular conditions such as neuropathic corneal pain  and dry eye disease .Okyo Pharma’s innovative lipid-conjugated small molecule platform enables urcosimod to target and modulate ocular G-protein coupled receptors , reducing inflammation and pain at the source. The drug’s design, combining ant","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/okyo-pharma-announces-ok-101-120000071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","QLD","USJW.SI","TSYW.SI",".IXIC","NQmain","TQQQ","USAW.SI","MNQmain","NVIW.SI","QID","PSQ","SQQQ","OKYO"],"gpt_icon":1},{"id":"2510604658","title":"OKYO Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2510604658","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510604658?lang=en_us&edition=fundamental","pubTime":"2025-02-11 01:02","pubTimestamp":1739206920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OKYO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 10, 2025 12:02 ET (17:02 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKYO"],"gpt_icon":0},{"id":"2510286997","title":"Yi Chen’s Buy Recommendation on OKYO Pharma: Promising Potential of OK-101 for Neuropathic Corneal Pain Amid Financial and Regulatory Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2510286997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510286997?lang=en_us&edition=fundamental","pubTime":"2025-02-10 23:15","pubTimestamp":1739200516,"startTime":"0","endTime":"0","summary":"In a report released on February 7, Yi Chen from H.C. Wainwright reiterated a Buy rating on OKYO Pharma Limited Sponsored ADR (OKYO – Research Repo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/yi-chens-buy-recommendation-on-okyo-pharma-promising-potential-of-ok-101-for-neuropathic-corneal-pain-amid-financial-and-regulatory-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/yi-chens-buy-recommendation-on-okyo-pharma-promising-potential-of-ok-101-for-neuropathic-corneal-pain-amid-financial-and-regulatory-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OKYO"],"gpt_icon":0},{"id":"2507595488","title":"Okyo Pharma CEO purchases 10,000 shares of company","url":"https://stock-news.laohu8.com/highlight/detail?id=2507595488","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507595488?lang=en_us&edition=fundamental","pubTime":"2025-01-31 20:06","pubTimestamp":1738325189,"startTime":"0","endTime":"0","summary":"OKYO Pharma (OKYO) has been notified that the CEO Gary Jacob has purchased 10,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 pe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/okyo-pharma-ceo-purchases-10000-shares-of-company?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/okyo-pharma-ceo-purchases-10000-shares-of-company?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSQ","QLD","USAW.SI",".IXIC","QID","SQQQ","MNQmain","TQQQ","USJW.SI","OKYO","TSYW.SI","NVIW.SI","BK4139","NQmain"],"gpt_icon":0},{"id":"2507510539","title":"OKYO Pharma Announces Chairman and CEO Acquire Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2507510539","media":"GlobeNewswire","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507510539?lang=en_us&edition=fundamental","pubTime":"2025-01-31 20:00","pubTimestamp":1738324800,"startTime":"0","endTime":"0","summary":"LONDON and NEW YORK, Jan.  31, 2025  (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/31/3018711/0/en/OKYO-Pharma-Announces-Chairman-and-CEO-Acquire-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKYO","USJW.SI","TSYW.SI","PSQ","MNQmain","TQQQ","NQmain","USAW.SI","SQQQ",".IXIC","QID","NVIW.SI","BK4139","QLD"],"gpt_icon":1},{"id":"2507473624","title":"Goldman Small Cap Research Publishes New Research Report on OKYO Pharma Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=2507473624","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507473624?lang=en_us&edition=fundamental","pubTime":"2025-01-30 22:45","pubTimestamp":1738248300,"startTime":"0","endTime":"0","summary":"Tracing its roots to 2018, OKYO is focused on the discovery and development of novel molecules to treat neuropathic corneal pain  and inflammatory dry eye disease . Its lead drug candidate OK-101 successfully completed a 240-patient Phase 2 trial in DED patients and is also currently being evaluated in a 48-patient, randomized, placebo-controlled Phase 2 trial in NCP patients that seeks to demonstrate OK-101's ability to reduce neuropathic corneal pain. If an award of orphan drug designation to NCP, should happen, it could lead to a multi-billion dollar market opportunity for OKYO.In the Opportunity Research report, analyst Rob Goldman reviews clinical and preclinical data on OKYO's lead candidate, the Company's inherent first-mover opportunities in the industry, upcoming milestones and how these milestones and the flurry of M&A in the segment can favorably impact OKYO's near term and long term valuations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/goldman-small-cap-research-publishes-144500276.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4127","BK4516","BK4139","IE00BFXG1179.USD","BK4552","IE00B19Z3581.USD","LU1791807156.HKD","LU1668664300.SGD","LU2237443622.USD","BK4504","IE00BSNM7G36.USD","LU2237443978.SGD","IE0034235188.USD","LU0106831901.USD","IE00B19Z3B42.SGD","OKYO","IE0004086264.USD","BK4588","BK4585","LU2237443382.USD","IE0002270589.USD","BK4533","LU2237443895.HKD","LU2237438978.USD","LU2237443465.HKD","BK4550","LU2237443549.SGD","IE0004091025.USD"],"gpt_icon":0},{"id":"2507669460","title":"OKYO Pharma Advances Clinical Trials with Encouraging Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2507669460","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507669460?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:56","pubTimestamp":1738187803,"startTime":"0","endTime":"0","summary":"An update from OKYO Pharma Limited Sponsored ADR ( ($OKYO) ) is now available. On January 29, 2025, OKYO Pharma Limited provided a clinical update ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/okyo-pharma-advances-clinical-trials-with-encouraging-interim-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/okyo-pharma-advances-clinical-trials-with-encouraging-interim-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OKYO"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OKYO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2023-08-15","symbol":"OKYO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1692072000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-12-30","symbol":"OKYO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1672376400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-08-16","symbol":"OKYO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1660622400000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OKYO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OKYO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1746158400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OKYO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OKYO","date":"2025-05-02","current":-4.969255,"percent":0.589388,"low":-330.07601,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"high":-0.078124,"avg":-29.793198,"sd":49.323344,"marketCap":53110750},"quantilePoints":[{"date":"2020-05-08","current":-4.493943,"twenty":-5.330256,"median":-2.690224,"eighty":-0.454307,"marketCap":16377267.7},{"date":"2020-05-15","current":-4.015864,"twenty":-5.330256,"median":-2.738752,"eighty":-0.454307,"marketCap":14266038.81},{"date":"2020-05-22","current":-4.876406,"twenty":-5.330256,"median":-2.863241,"eighty":-0.454307,"marketCap":17411048.17},{"date":"2020-05-29","current":-3.799302,"twenty":-5.330256,"median":-2.863241,"eighty":-0.454307,"marketCap":13743594.87},{"date":"2020-06-05","current":-8.605422,"twenty":-5.363786,"median":-2.863241,"eighty":-0.454307,"marketCap":32077883.62},{"date":"2020-06-12","current":-12.047591,"twenty":-5.736948,"median":-2.925485,"eighty":-0.454307,"marketCap":44245009.71},{"date":"2020-06-19","current":-12.621286,"twenty":-5.93661,"median":-2.96409,"eighty":-0.454307,"marketCap":45746019.14},{"date":"2020-06-26","current":-11.473896,"twenty":-5.975988,"median":-2.98773,"eighty":-0.464691,"marketCap":41452468.41},{"date":"2020-07-02","current":-14.916065,"twenty":-5.975988,"median":-2.98773,"eighty":-0.467287,"marketCap":54531495.11},{"date":"2020-07-10","current":-14.34237,"twenty":-6.215027,"median":-2.98773,"eighty":-0.467287,"marketCap":53149480.96},{"date":"2020-07-17","current":-18.931929,"twenty":-6.215027,"median":-2.98773,"eighty":-0.467287,"marketCap":69574950.78},{"date":"2020-07-24","current":-26.963656,"twenty":-6.215027,"median":-2.98773,"eighty":-0.467287,"marketCap":101072466.36},{"date":"2020-07-31","current":-33.847994,"twenty":-6.585095,"median":-3.048921,"eighty":-0.467287,"marketCap":130340593.34},{"date":"2020-08-07","current":-41.306027,"twenty":-7.171185,"median":-3.049974,"eighty":-0.475075,"marketCap":158066999.18},{"date":"2020-08-14","current":-30.405825,"twenty":-7.171185,"median":-3.112218,"eighty":-0.480267,"marketCap":116781814.73},{"date":"2020-08-21","current":-34.995384,"twenty":-7.171185,"median":-3.112218,"eighty":-0.480267,"marketCap":134266737.79},{"date":"2020-08-28","current":-31.553215,"twenty":-7.171185,"median":-3.112218,"eighty":-0.480267,"marketCap":123417365.31},{"date":"2020-09-04","current":-33.623515,"twenty":-7.171185,"median":-3.112218,"eighty":-0.484161,"marketCap":113207217.35},{"date":"2020-09-11","current":-29.008523,"twenty":-7.171185,"median":-3.112218,"eighty":-0.486757,"marketCap":94567814.96},{"date":"2020-09-18","current":-26.701027,"twenty":-7.649264,"median":-3.112218,"eighty":-0.491949,"marketCap":88220414.56},{"date":"2020-09-25","current":-26.371385,"twenty":-7.888304,"median":-3.155321,"eighty":-0.499737,"marketCap":85433451.04},{"date":"2020-10-02","current":-25.052815,"twenty":-8.127343,"median":-3.155321,"eighty":-0.499737,"marketCap":82692220.48},{"date":"2020-10-09","current":-31.909375,"twenty":-8.127343,"median":-3.236707,"eighty":-0.499737,"marketCap":105870481.87},{"date":"2020-10-16","current":-29.008523,"twenty":-8.605422,"median":-3.250937,"eighty":-0.512717,"marketCap":95555962.7},{"date":"2020-10-23","current":-29.667807,"twenty":-8.605422,"median":-3.250937,"eighty":-0.53738,"marketCap":98717116.13},{"date":"2020-10-30","current":-26.371385,"twenty":-8.873147,"median":-3.250937,"eighty":-0.547764,"marketCap":87135788.87},{"date":"2020-11-06","current":-23.734246,"twenty":-8.89227,"median":-3.250937,"eighty":-0.564638,"marketCap":79740438.68},{"date":"2020-11-13","current":-22.415677,"twenty":-9.92492,"median":-3.250937,"eighty":-0.584108,"marketCap":75298510.31},{"date":"2020-11-20","current":-20.767465,"twenty":-10.326507,"median":-3.250937,"eighty":-0.584108,"marketCap":70401685.45},{"date":"2020-11-27","current":-21.097108,"twenty":-10.747468,"median":-3.250937,"eighty":-0.584108,"marketCap":71715543.94},{"date":"2020-12-04","current":-128.314516,"twenty":-10.995817,"median":-3.250937,"eighty":-0.584108,"marketCap":65688265.01},{"date":"2020-12-11","current":-132.739156,"twenty":-11.282665,"median":-3.250937,"eighty":-0.584108,"marketCap":66696379.74},{"date":"2020-12-18","current":-137.163795,"twenty":-11.473896,"median":-3.250937,"eighty":-0.584108,"marketCap":70333137.23},{"date":"2020-12-24","current":-132.739156,"twenty":-11.473896,"median":-3.250937,"eighty":-0.584108,"marketCap":68321534.31},{"date":"2020-12-31","current":-132.739156,"twenty":-11.473896,"median":-3.250937,"eighty":-0.584108,"marketCap":68869084.16},{"date":"2021-01-08","current":-146.013071,"twenty":-12.047591,"median":-3.250937,"eighty":-0.584108,"marketCap":75297488.13},{"date":"2021-01-15","current":-212.382651,"twenty":-12.522356,"median":-3.250937,"eighty":-0.584108,"marketCap":109705246.85},{"date":"2021-01-22","current":-190.259458,"twenty":-12.522356,"median":-3.250937,"eighty":-0.584108,"marketCap":98786534.86},{"date":"2021-01-29","current":-154.862349,"twenty":-12.850764,"median":-3.298952,"eighty":-0.584108,"marketCap":80717549.51},{"date":"2021-02-05","current":-154.862349,"twenty":-13.357179,"median":-3.298952,"eighty":-0.584108,"marketCap":80782922.21},{"date":"2021-02-12","current":-163.711625,"twenty":-13.357179,"median":-3.298952,"eighty":-0.584108,"marketCap":86127368.38},{"date":"2021-02-19","current":-161.499308,"twenty":-13.858074,"median":-3.298952,"eighty":-0.584108,"marketCap":86046316.81},{"date":"2021-02-26","current":-146.013071,"twenty":-14.192004,"median":-3.298952,"eighty":-0.584108,"marketCap":77268791.25},{"date":"2021-03-05","current":-146.067345,"twenty":-15.026828,"median":-3.298952,"eighty":-0.584108,"marketCap":76619979.29},{"date":"2021-03-12","current":-146.067345,"twenty":-16.201142,"median":-3.298952,"eighty":-0.588548,"marketCap":77166412.72},{"date":"2021-03-19","current":-137.21478,"twenty":-16.696474,"median":-3.298952,"eighty":-0.59596,"marketCap":72353869.32},{"date":"2021-03-26","current":-139.427921,"twenty":-16.696474,"median":-3.346553,"eighty":-0.597089,"marketCap":73075722.01},{"date":"2021-04-01","current":-137.21478,"twenty":-16.696474,"median":-3.346553,"eighty":-0.607473,"marketCap":72113713.75},{"date":"2021-04-09","current":-135.444268,"twenty":-16.696474,"median":-3.346553,"eighty":-0.649009,"marketCap":70632277.59},{"date":"2021-04-16","current":-135.444268,"twenty":-16.696474,"median":-3.361196,"eighty":-0.649009,"marketCap":71136975.15},{"date":"2021-04-23","current":-128.362212,"twenty":-17.497692,"median":-3.361196,"eighty":-0.654201,"marketCap":67536871.76},{"date":"2021-04-30","current":-137.21478,"twenty":-18.172443,"median":-3.454562,"eighty":-0.680661,"marketCap":72030035.5},{"date":"2021-05-07","current":-185.190841,"twenty":-18.818768,"median":-3.485684,"eighty":-0.718504,"marketCap":98438603.46},{"date":"2021-05-14","current":-168.587526,"twenty":-21.097108,"median":-3.585592,"eighty":-0.778811,"marketCap":90276023.73},{"date":"2021-05-21","current":-159.647277,"twenty":-21.42675,"median":-3.585592,"eighty":-0.780888,"marketCap":85948886.46},{"date":"2021-05-28","current":-149.429852,"twenty":-22.28382,"median":-3.585592,"eighty":-0.793608,"marketCap":80536012.42},{"date":"2021-06-04","current":-151.984208,"twenty":-22.947793,"median":-3.585592,"eighty":-0.811262,"marketCap":81823340.32},{"date":"2021-06-11","current":-151.984208,"twenty":-23.074961,"median":-3.585592,"eighty":-0.843712,"marketCap":81467857.65},{"date":"2021-06-18","current":-151.984208,"twenty":-23.670416,"median":-3.672418,"eighty":-0.876163,"marketCap":79691783.26},{"date":"2021-06-25","current":-151.984208,"twenty":-23.670416,"median":-3.672418,"eighty":-0.876163,"marketCap":80338043.71},{"date":"2021-07-02","current":-159.647277,"twenty":-23.734246,"median":-3.734662,"eighty":-0.973514,"marketCap":83691379.5},{"date":"2021-07-09","current":-150.70703,"twenty":-24.446273,"median":-3.734662,"eighty":-1.103316,"marketCap":79205709.07},{"date":"2021-07-16","current":-144.32114,"twenty":-25.052815,"median":-3.734662,"eighty":-1.147019,"marketCap":75615283.33},{"date":"2021-07-23","current":-137.935247,"twenty":-25.292302,"median":-3.734662,"eighty":-1.203942,"marketCap":72110398.95},{"date":"2021-07-30","current":-134.103713,"twenty":-26.107671,"median":-3.734662,"eighty":-1.433908,"marketCap":70866793.68},{"date":"2021-08-06","current":-19.502745,"twenty":-25.778028,"median":-3.73832,"eighty":-1.542128,"marketCap":69326067.48},{"date":"2021-08-13","current":-18.55601,"twenty":-25.7121,"median":-3.73832,"eighty":-1.609765,"marketCap":65920500.88},{"date":"2021-08-20","current":-18.55601,"twenty":-25.535396,"median":-3.811967,"eighty":-1.650347,"marketCap":64773214.31},{"date":"2021-08-27","current":-18.55601,"twenty":-25.292302,"median":-3.824632,"eighty":-1.711221,"marketCap":65381342.44},{"date":"2021-09-03","current":-18.366663,"twenty":-25.090766,"median":-3.824632,"eighty":-1.808431,"marketCap":65271363.01},{"date":"2021-09-10","current":-17.419928,"twenty":-25.052815,"median":-3.859151,"eighty":-1.843696,"marketCap":61833132.54},{"date":"2021-09-17","current":-17.041234,"twenty":-25.052815,"median":-3.859151,"eighty":-1.925002,"marketCap":60077948.48},{"date":"2021-09-24","current":-16.567866,"twenty":-25.052815,"median":-3.89159,"eighty":-1.972831,"marketCap":58052214.51},{"date":"2021-10-01","current":-15.621131,"twenty":-25.052815,"median":-3.920248,"eighty":-1.972831,"marketCap":54244802.55},{"date":"2021-10-08","current":-17.419928,"twenty":-24.85503,"median":-4.015864,"eighty":-1.972831,"marketCap":60895410.84},{"date":"2021-10-15","current":-18.55601,"twenty":-24.683616,"median":-4.045884,"eighty":-1.972831,"marketCap":65453320.58},{"date":"2021-10-22","current":-23.66838,"twenty":-24.499016,"median":-4.111479,"eighty":-1.972831,"marketCap":83511660.66},{"date":"2021-10-29","current":-22.267212,"twenty":-24.39353,"median":-4.111479,"eighty":-1.972831,"marketCap":78114007.5},{"date":"2021-11-05","current":-20.638827,"twenty":-24.214521,"median":-4.111479,"eighty":-1.972831,"marketCap":71363386.44},{"date":"2021-11-12","current":-23.289686,"twenty":-23.87862,"median":-4.232617,"eighty":-1.972831,"marketCap":80074572.11},{"date":"2021-11-19","current":-25.59972,"twenty":-24.683616,"median":-4.302711,"eighty":-1.972831,"marketCap":88354693.2},{"date":"2021-11-26","current":-26.319239,"twenty":-25.052815,"median":-4.302711,"eighty":-1.972831,"marketCap":89842434.41},{"date":"2021-12-03","current":-27.644668,"twenty":-25.218806,"median":-4.302711,"eighty":-1.972831,"marketCap":93693091.37},{"date":"2021-12-10","current":-26.508586,"twenty":-25.561851,"median":-4.421545,"eighty":-1.972831,"marketCap":89917592.34},{"date":"2021-12-17","current":-27.455321,"twenty":-25.909885,"median":-4.493943,"eighty":-1.972831,"marketCap":93395896.54},{"date":"2021-12-23","current":-27.076627,"twenty":-26.360956,"median":-4.493943,"eighty":-1.972831,"marketCap":93019964.62},{"date":"2021-12-31","current":-27.076627,"twenty":-26.484861,"median":-4.493943,"eighty":-1.972831,"marketCap":93977219.3},{"date":"2022-01-07","current":-26.129892,"twenty":-26.662539,"median":-4.613438,"eighty":-1.972831,"marketCap":90889445.12},{"date":"2022-01-14","current":-26.129892,"twenty":-26.484861,"median":-4.828664,"eighty":-1.974266,"marketCap":91585430.26},{"date":"2022-01-21","current":-25.183157,"twenty":-26.389961,"median":-4.876406,"eighty":-1.980005,"marketCap":87525085.76},{"date":"2022-01-28","current":-13.024565,"twenty":-26.371385,"median":-4.972021,"eighty":-2.008701,"marketCap":68418747.65},{"date":"2022-02-04","current":-11.78413,"twenty":-26.371385,"median":-4.984427,"eighty":-2.008701,"marketCap":62465405.82},{"date":"2022-02-11","current":-12.900522,"twenty":-26.371385,"median":-4.984427,"eighty":-2.037396,"marketCap":68643570.91},{"date":"2022-02-18","current":-19.846956,"twenty":-26.371385,"median":-5.258869,"eighty":-2.037396,"marketCap":105517960.7},{"date":"2022-02-25","current":-26.345185,"twenty":-26.3751,"median":-5.294562,"eighty":-2.037396,"marketCap":138233083.01},{"date":"2022-03-04","current":-26.345185,"twenty":-26.902555,"median":-5.330256,"eighty":-2.037396,"marketCap":136218215.22},{"date":"2022-03-11","current":-24.588839,"twenty":-26.902555,"median":-5.330256,"eighty":-2.037396,"marketCap":125626290.43},{"date":"2022-03-18","current":-24.588839,"twenty":-26.902555,"median":-5.330256,"eighty":-2.037396,"marketCap":126770123.33},{"date":"2022-03-25","current":-24.588839,"twenty":-26.902555,"median":-5.330256,"eighty":-2.04457,"marketCap":126880465.8},{"date":"2022-04-01","current":-21.954321,"twenty":-26.902555,"median":-5.330256,"eighty":-2.04457,"marketCap":112591214.25},{"date":"2022-04-08","current":-21.515234,"twenty":-26.902555,"median":-5.517017,"eighty":-2.04457,"marketCap":109576744.55},{"date":"2022-04-14","current":-21.515234,"twenty":-26.902555,"median":-5.840704,"eighty":-2.04457,"marketCap":109943102.3},{"date":"2022-04-22","current":-21.515234,"twenty":-26.902555,"median":-5.975988,"eighty":-2.04457,"marketCap":108163196.24},{"date":"2022-04-29","current":-21.515234,"twenty":-26.902555,"median":-5.975988,"eighty":-2.062505,"marketCap":105671738.8},{"date":"2022-05-06","current":-21.515234,"twenty":-26.902555,"median":-6.215027,"eighty":-2.068244,"marketCap":104095874.86},{"date":"2022-05-13","current":-20.637062,"twenty":-26.902555,"median":-6.215027,"eighty":-2.068244,"marketCap":98795219.68},{"date":"2022-05-20","current":-15.76814,"twenty":-26.902555,"median":-6.603097,"eighty":-2.068244,"marketCap":76903414.15},{"date":"2022-05-27","current":-9.945501,"twenty":-26.902555,"median":-7.171185,"eighty":-2.11387,"marketCap":49089341.63},{"date":"2022-06-03","current":-9.945501,"twenty":-26.902555,"median":-7.171185,"eighty":-2.151462,"marketCap":48671826.49},{"date":"2022-06-10","current":-9.945501,"twenty":-26.902555,"median":-7.171185,"eighty":-2.152179,"marketCap":47937926.7},{"date":"2022-06-17","current":-10.487983,"twenty":-26.902555,"median":-7.171185,"eighty":-2.152179,"marketCap":50095430.69},{"date":"2022-06-24","current":-10.487983,"twenty":-26.91783,"median":-7.171185,"eighty":-2.152179,"marketCap":50435914.36},{"date":"2022-07-01","current":-9.945501,"twenty":-26.91783,"median":-7.888304,"eighty":-2.152179,"marketCap":46813367.82},{"date":"2022-07-08","current":-9.945501,"twenty":-26.91783,"median":-7.888304,"eighty":-2.152179,"marketCap":46829141.85},{"date":"2022-07-15","current":-9.945501,"twenty":-26.91783,"median":-8.127343,"eighty":-2.152179,"marketCap":46190456.52},{"date":"2022-07-22","current":-9.945501,"twenty":-26.91783,"median":-8.605422,"eighty":-2.152179,"marketCap":46795916.11},{"date":"2022-07-29","current":-9.945501,"twenty":-26.91783,"median":-8.605422,"eighty":-2.154331,"marketCap":47347648.65},{"date":"2022-08-05","current":-9.945501,"twenty":-26.91783,"median":-8.89227,"eighty":-2.154331,"marketCap":46870881.56},{"date":"2022-08-12","current":-9.945501,"twenty":-26.91783,"median":-9.083501,"eighty":-2.154331,"marketCap":47174876.35},{"date":"2022-08-19","current":-9.78603,"twenty":-26.91783,"median":-9.403019,"eighty":-2.155766,"marketCap":45966750.14},{"date":"2022-08-26","current":-9.074319,"twenty":-26.91783,"median":-9.430175,"eighty":-2.292788,"marketCap":42504218.2},{"date":"2022-09-02","current":-11.565309,"twenty":-26.91783,"median":-9.78603,"eighty":-2.390395,"marketCap":53230259.5},{"date":"2022-09-09","current":-14.056299,"twenty":-26.91783,"median":-9.945501,"eighty":-2.390395,"marketCap":64720708.18},{"date":"2022-09-16","current":-15.123865,"twenty":-26.91783,"median":-9.945501,"eighty":-2.614263,"marketCap":68691283.84},{"date":"2022-09-23","current":-14.234226,"twenty":-26.91783,"median":-9.945501,"eighty":-2.677242,"marketCap":61880656.83},{"date":"2022-09-30","current":-12.988732,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":57552095.43},{"date":"2022-10-07","current":-11.565309,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":51142438.53},{"date":"2022-10-14","current":-11.565309,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":51585883.34},{"date":"2022-10-21","current":-12.454948,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":55512308.19},{"date":"2022-10-28","current":-11.565309,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":53294413.16},{"date":"2022-11-04","current":-10.67567,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":47949593.94},{"date":"2022-11-11","current":-9.78603,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":45795805.68},{"date":"2022-11-18","current":-9.430175,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":44703422.62},{"date":"2022-11-25","current":-10.67567,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":51312342.41},{"date":"2022-12-02","current":-9.78603,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":47666052.57},{"date":"2022-12-09","current":-9.78603,"twenty":-26.91783,"median":-9.78603,"eighty":-2.714148,"marketCap":47868342.91},{"date":"2022-12-16","current":-8.006752,"twenty":-26.91783,"median":-9.78603,"eighty":-2.714148,"marketCap":38691907.59},{"date":"2022-12-23","current":-9.78603,"twenty":-26.91783,"median":-9.78603,"eighty":-2.714148,"marketCap":46928536.8},{"date":"2022-12-30","current":-5.282797,"twenty":-26.91783,"median":-9.78603,"eighty":-2.714148,"marketCap":42624267.73},{"date":"2023-01-06","current":-4.754517,"twenty":-26.91783,"median":-9.78603,"eighty":-2.863241,"marketCap":38350751.03},{"date":"2023-01-13","current":-6.128044,"twenty":-26.91783,"median":-9.78603,"eighty":-2.900587,"marketCap":50081369.07},{"date":"2023-01-20","current":-5.811076,"twenty":-26.91783,"median":-9.78603,"eighty":-2.96409,"marketCap":48178895.37},{"date":"2023-01-27","current":-5.705421,"twenty":-26.91783,"median":-9.78603,"eighty":-2.98773,"marketCap":47304672.76},{"date":"2023-02-03","current":-6.2337,"twenty":-26.91783,"median":-9.78603,"eighty":-2.98773,"marketCap":50487038.29},{"date":"2023-02-10","current":-6.445012,"twenty":-26.91783,"median":-9.78603,"eighty":-3.049974,"marketCap":52086959.78},{"date":"2023-02-17","current":-11.428401,"twenty":-26.91783,"median":-9.78603,"eighty":-3.112218,"marketCap":91807447.31},{"date":"2023-02-24","current":-7.407297,"twenty":-26.91783,"median":-9.78603,"eighty":-3.112218,"marketCap":59258151.15},{"date":"2023-03-03","current":-6.391439,"twenty":-26.91783,"median":-9.78603,"eighty":-3.112218,"marketCap":51264830.87},{"date":"2023-03-10","current":-6.45493,"twenty":-26.91783,"median":-9.78603,"eighty":-3.155321,"marketCap":52132508.38},{"date":"2023-03-17","current":-6.81208,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":55519867.82},{"date":"2023-03-24","current":-4.582672,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":37515932.96},{"date":"2023-03-31","current":-5.078096,"twenty":-26.902555,"median":-9.78603,"eighty":-3.250937,"marketCap":42069035.78},{"date":"2023-04-06","current":-4.33496,"twenty":-26.902555,"median":-9.78603,"eighty":-3.250937,"marketCap":36093433.8},{"date":"2023-04-14","current":-3.839536,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":32199878.52},{"date":"2023-04-21","current":-3.839536,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":32012252.7},{"date":"2023-04-28","current":-4.211104,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":35228639.42},{"date":"2023-05-05","current":-4.95424,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":41687101.52},{"date":"2023-05-12","current":-0.078124,"twenty":-26.990461,"median":-9.78603,"eighty":-3.298952,"marketCap":654641.81},{"date":"2023-05-19","current":-3.467968,"twenty":-26.990461,"median":-9.78603,"eighty":-3.298952,"marketCap":28826717.64},{"date":"2023-05-26","current":-3.507829,"twenty":-26.990461,"median":-9.78603,"eighty":-3.298952,"marketCap":28953912},{"date":"2023-06-02","current":-3.997814,"twenty":-26.990461,"median":-9.78603,"eighty":-3.298952,"marketCap":33525582},{"date":"2023-06-09","current":-4.405629,"twenty":-26.990461,"median":-9.78603,"eighty":-3.346553,"marketCap":37021536},{"date":"2023-06-16","current":-3.867639,"twenty":-26.990461,"median":-9.78603,"eighty":-3.355339,"marketCap":33048107},{"date":"2023-06-23","current":-3.62005,"twenty":-27.003864,"median":-9.78603,"eighty":-3.42344,"marketCap":30878926},{"date":"2023-06-30","current":-3.504633,"twenty":-27.017266,"median":-9.78603,"eighty":-3.485684,"marketCap":29602937},{"date":"2023-07-07","current":-3.513265,"twenty":-27.017266,"median":-9.78603,"eighty":-3.485684,"marketCap":29858135},{"date":"2023-07-14","current":-3.133612,"twenty":-27.017266,"median":-9.78603,"eighty":-3.485684,"marketCap":27484796},{"date":"2023-07-21","current":-3.618398,"twenty":-27.017266,"median":-9.78603,"eighty":-3.508916,"marketCap":31134124},{"date":"2023-07-28","current":-5.570448,"twenty":-27.017266,"median":-9.78603,"eighty":-3.585592,"marketCap":47977175},{"date":"2023-08-04","current":-4.74099,"twenty":-27.017266,"median":-9.78603,"eighty":-3.585592,"marketCap":40374172},{"date":"2023-08-11","current":-3.747015,"twenty":-27.017266,"median":-9.78603,"eighty":-3.59396,"marketCap":31941592},{"date":"2023-08-18","current":-4.640029,"twenty":-27.017266,"median":-9.78603,"eighty":-3.659792,"marketCap":39607574},{"date":"2023-08-25","current":-2.990794,"twenty":-27.017266,"median":-9.78603,"eighty":-3.659792,"marketCap":50148300},{"date":"2023-09-01","current":-3.053779,"twenty":-27.017266,"median":-9.78603,"eighty":-3.672418,"marketCap":51362080},{"date":"2023-09-07","current":-3.057074,"twenty":-27.017266,"median":-9.78603,"eighty":-3.672418,"marketCap":50595482},{"date":"2023-09-15","current":-2.746027,"twenty":-27.039861,"median":-9.78603,"eighty":-3.682592,"marketCap":45229294},{"date":"2023-09-22","current":-3.363611,"twenty":-27.039861,"median":-9.78603,"eighty":-3.682592,"marketCap":54887791},{"date":"2023-09-29","current":-3.257767,"twenty":-27.039861,"median":-9.78603,"eighty":-3.682592,"marketCap":52771295},{"date":"2023-10-06","current":-4.371516,"twenty":-27.058244,"median":-9.78603,"eighty":-3.734662,"marketCap":70549860},{"date":"2023-10-12","current":-3.029811,"twenty":-27.067435,"median":-9.78603,"eighty":-3.734662,"marketCap":49102702},{"date":"2023-10-20","current":-2.801444,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":45151910},{"date":"2023-10-27","current":-2.845109,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":45716309},{"date":"2023-11-03","current":-3.277386,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":52959825},{"date":"2023-11-10","current":-3.509737,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":57209687},{"date":"2023-11-17","current":-3.352312,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":55248212},{"date":"2023-11-24","current":-3.243542,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":53940562},{"date":"2023-12-01","current":-4.015069,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":53286737},{"date":"2023-12-08","current":-4.187496,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":55575125},{"date":"2023-12-15","current":-4.162863,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":55248212},{"date":"2023-12-22","current":-4.307366,"twenty":-27.076627,"median":-9.78603,"eighty":-3.73832,"marketCap":57166006},{"date":"2023-12-29","current":-4.733094,"twenty":-27.076627,"median":-9.78603,"eighty":-3.750951,"marketCap":62816134},{"date":"2024-01-05","current":-4.25728,"twenty":-27.076627,"median":-9.78603,"eighty":-3.799302,"marketCap":56501285},{"date":"2024-01-12","current":-4.232238,"twenty":-27.076627,"median":-9.78603,"eighty":-3.824632,"marketCap":56168924},{"date":"2024-01-19","current":-4.182152,"twenty":-27.076627,"median":-9.78603,"eighty":-3.824632,"marketCap":55504203},{"date":"2024-01-26","current":-3.956767,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":52512959},{"date":"2024-02-02","current":-3.731381,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":49521714},{"date":"2024-02-09","current":-3.581124,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":47527551},{"date":"2024-02-16","current":-3.505996,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":46530470},{"date":"2024-02-23","current":-3.73664,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":49591510},{"date":"2024-03-01","current":-3.330696,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":44203946},{"date":"2024-03-08","current":-3.531289,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":46866154},{"date":"2024-03-15","current":-3.556081,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":47195191},{"date":"2024-03-22","current":-4.407537,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":58495448},{"date":"2024-03-28","current":-3.756424,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839937,"marketCap":49854075},{"date":"2024-04-05","current":-3.756424,"twenty":-27.076627,"median":-9.78603,"eighty":-3.841539,"marketCap":49854075},{"date":"2024-04-12","current":-3.405824,"twenty":-27.076627,"median":-9.78603,"eighty":-3.841539,"marketCap":45201028},{"date":"2024-04-19","current":-3.669525,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":48700784},{"date":"2024-04-26","current":-3.622946,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":48082593},{"date":"2024-05-03","current":-3.869117,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":51349697},{"date":"2024-05-10","current":-3.781467,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":50186435},{"date":"2024-05-17","current":-3.881638,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":51515877},{"date":"2024-05-24","current":-3.716606,"twenty":-27.076627,"median":-9.78603,"eighty":-3.824632,"marketCap":49325621},{"date":"2024-05-31","current":-3.481203,"twenty":-27.076627,"median":-9.78603,"eighty":-3.807241,"marketCap":46201433},{"date":"2024-06-07","current":-3.355739,"twenty":-27.076627,"median":-9.78603,"eighty":-3.78464,"marketCap":44536307},{"date":"2024-06-14","current":-3.406075,"twenty":-27.076627,"median":-9.78603,"eighty":-3.756424,"marketCap":45204351},{"date":"2024-06-21","current":-3.10531,"twenty":-27.076627,"median":-9.78603,"eighty":-3.754542,"marketCap":41212702},{"date":"2024-06-28","current":-2.831843,"twenty":-27.076627,"median":-9.78603,"eighty":-3.737141,"marketCap":37583325},{"date":"2024-07-05","current":-2.955053,"twenty":-27.076627,"median":-9.78603,"eighty":-3.731381,"marketCap":39218539},{"date":"2024-07-12","current":-3.681295,"twenty":-27.076627,"median":-9.78603,"eighty":-3.706338,"marketCap":48856993},{"date":"2024-07-15","current":-3.981809,"twenty":-27.076627,"median":-9.78603,"eighty":-3.706338,"marketCap":52845319},{"date":"2024-08-02","current":-2.491761,"twenty":-27.076627,"median":-9.945501,"eighty":-3.693817,"marketCap":33069869},{"date":"2024-08-09","current":-2.47924,"twenty":-27.076627,"median":-9.945501,"eighty":-3.681295,"marketCap":32903689},{"date":"2024-08-16","current":-1.936033,"twenty":-27.076627,"median":-9.945501,"eighty":-3.676587,"marketCap":32574652},{"date":"2024-08-23","current":-2.091459,"twenty":-27.076627,"median":-9.78603,"eighty":-3.656253,"marketCap":35189768},{"date":"2024-08-30","current":-2.674655,"twenty":-27.076627,"median":-9.78603,"eighty":-3.642585,"marketCap":45002300},{"date":"2024-09-06","current":-2.11157,"twenty":-27.076627,"median":-9.78603,"eighty":-3.627904,"marketCap":35528131},{"date":"2024-09-13","current":-2.081404,"twenty":-27.076627,"median":-9.78603,"eighty":-3.606167,"marketCap":35020587},{"date":"2024-09-20","current":-2.051239,"twenty":-27.076627,"median":-9.78603,"eighty":-3.588711,"marketCap":34513042},{"date":"2024-09-27","current":-2.011019,"twenty":-27.076627,"median":-9.78603,"eighty":-3.585592,"marketCap":33836316},{"date":"2024-10-04","current":-2.071349,"twenty":-27.076627,"median":-9.78603,"eighty":-3.585592,"marketCap":34851405},{"date":"2024-10-11","current":-2.011019,"twenty":-27.076627,"median":-9.78603,"eighty":-3.580106,"marketCap":33836316},{"date":"2024-10-18","current":-2.031129,"twenty":-27.076627,"median":-9.78603,"eighty":-3.540898,"marketCap":34174679},{"date":"2024-10-25","current":-2.21212,"twenty":-27.076627,"median":-9.78603,"eighty":-3.531038,"marketCap":37219947},{"date":"2024-10-31","current":-2.342837,"twenty":-27.076627,"median":-9.78603,"eighty":-3.509737,"marketCap":39419308},{"date":"2024-11-08","current":-2.272451,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":38235037},{"date":"2024-11-15","current":-2.131881,"twenty":-27.076627,"median":-9.78603,"eighty":-3.477134,"marketCap":35869878},{"date":"2024-11-22","current":-2.15179,"twenty":-27.076627,"median":-9.78603,"eighty":-3.458705,"marketCap":36204858},{"date":"2024-11-29","current":-2.054054,"twenty":-27.076627,"median":-9.78603,"eighty":-3.453872,"marketCap":34560413},{"date":"2024-12-06","current":-2.035151,"twenty":-27.076627,"median":-9.78603,"eighty":-3.4105,"marketCap":34242351},{"date":"2024-12-13","current":-2.13168,"twenty":-27.076627,"median":-9.78603,"eighty":-3.401864,"marketCap":35866494},{"date":"2024-12-20","current":-2.19201,"twenty":-27.076627,"median":-9.78603,"eighty":-3.401864,"marketCap":36881584},{"date":"2024-12-27","current":-2.15179,"twenty":-27.076627,"median":-9.78603,"eighty":-3.401864,"marketCap":36204858},{"date":"2025-01-03","current":-2.272451,"twenty":-27.076627,"median":-9.78603,"eighty":-3.401864,"marketCap":38235037},{"date":"2025-01-10","current":-2.584159,"twenty":-27.076627,"median":-9.78603,"eighty":-3.403621,"marketCap":43479666},{"date":"2025-01-17","current":-2.101514,"twenty":-27.076627,"median":-9.78603,"eighty":-3.401462,"marketCap":35358950},{"date":"2025-01-24","current":-2.081404,"twenty":-27.076627,"median":-9.78603,"eighty":-3.363473,"marketCap":35020587},{"date":"2025-01-31","current":-2.218676,"twenty":-27.076627,"median":-9.78603,"eighty":-3.352312,"marketCap":37330240},{"date":"2025-02-07","current":-3.605806,"twenty":-27.076627,"median":-9.78603,"eighty":-3.358188,"marketCap":38538382},{"date":"2025-02-14","current":-3.381633,"twenty":-27.076627,"median":-9.78603,"eighty":-3.368762,"marketCap":36142459},{"date":"2025-02-21","current":-3.461015,"twenty":-27.076627,"median":-9.78603,"eighty":-3.403621,"marketCap":36990874},{"date":"2025-02-28","current":-3.651529,"twenty":-27.076627,"median":-9.78603,"eighty":-3.41421,"marketCap":39027069},{"date":"2025-03-07","current":-4.350083,"twenty":-27.076627,"median":-9.78603,"eighty":-3.453209,"marketCap":46493117},{"date":"2025-03-14","current":-4.731112,"twenty":-27.076627,"median":-9.78603,"eighty":-3.458726,"marketCap":50565507},{"date":"2025-03-21","current":-4.000806,"twenty":-27.076627,"median":-9.78603,"eighty":-3.467968,"marketCap":42760093},{"date":"2025-03-28","current":-4.540597,"twenty":-27.076627,"median":-9.78603,"eighty":-3.474421,"marketCap":48529312},{"date":"2025-04-04","current":-3.8938,"twenty":-27.076627,"median":-9.78603,"eighty":-3.504633,"marketCap":41616430},{"date":"2025-04-11","current":-3.39751,"twenty":-27.076627,"median":-9.78603,"eighty":-3.504906,"marketCap":36312142},{"date":"2025-04-17","current":-3.587707,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":38344944},{"date":"2025-04-25","current":-4.800015,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":51301931},{"date":"2025-05-02","current":-4.969255,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":53110750}],"updateTime":1746270181378}}}